These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 6455443)

  • 1. Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study.
    Gavan TL; Jones RN; Barry AL; Fuchs PC; Gerlach EH; Matsen JM; Reller LB; Thornsberry C; Thrupp LD
    J Clin Microbiol; 1981 Jul; 14(1):67-72. PubMed ID: 6455443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agar disk diffusion susceptibility characteristics of azlocillin, carbenicillin, mezlocillin, piperacillin, and ticarcillin.
    Phaneuf D; Neu HC
    Antimicrob Agents Chemother; 1979 Nov; 16(5):625-30. PubMed ID: 118706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of azlocillin, carbenicillin, mezlocillin and piperacillin against Pseudomonas aeruginosa.
    Høiby N; Bremmelgaard A; Schouenborg P
    Scand J Infect Dis Suppl; 1981; 29():27-30. PubMed ID: 6458882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Apalcillin: in vitro activity compared with that of carbenicillin, ticarcillin, mezlocillin, piperacillin against Enterobacteriaceae and Acinetobacter].
    Quentin C; Sageaux JC; Bebear C; Latrille J
    Pathol Biol (Paris); 1983 Jun; 31(6):463-6. PubMed ID: 6224123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of mezlocillin, piperacillin, Bay k 4999 with carbenicillin and ticarcillin against enterobacteriaceae and Pseudomonas aeruginosa.
    Sobel JD; Levison ME; Kaye D
    Infection; 1980; 8(3):121-2. PubMed ID: 6448229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefsulodin: antibacterial activity and tentative interpretive zone standards for the disk susceptibility test.
    Barry AL; Jones RN; Thornsberry C
    Antimicrob Agents Chemother; 1981 Oct; 20(4):525-9. PubMed ID: 6211134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piperacillin susceptibility tests by the single-disk agar diffusion technique.
    Barry AL; Thornsberry C; Badal RE; Baker CN; Jones RN; Gerlach EH
    Antimicrob Agents Chemother; 1979 Sep; 16(3):378-85. PubMed ID: 507794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of piperacillin compared with that of carbenicillin, ticarcillin, ampicillin, cephalothin, and cefamandole against Pseudomonas aeruginosa and Enterobacteriaceae.
    Shah PP; Briedis DJ; Robson HG; Conterato JP
    Antimicrob Agents Chemother; 1979 Mar; 15(3):346-50. PubMed ID: 111609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proposed mezlocillin disk control values for staphylococcus aureus ATCC 25923, Escherichia coli ATCC 25922, and Pseudomonas aeruginosa ATCC 27853.
    Prior RB; Fass RJ
    Am J Clin Pathol; 1982 Mar; 77(3):332-3. PubMed ID: 6462053
    [No Abstract]   [Full Text] [Related]  

  • 10. Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitin.
    Jones RN; Thornsberry C; Barry AL; Fuchs PC; Gavan TL; Gerlach EH
    J Antibiot (Tokyo); 1977 Dec; 30(12):1107-14. PubMed ID: 599084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A turbidimetric study of the responses of selected strains of Pseudomonas aeruginosa to eight antipseudomonal beta-lactam antibiotics.
    Greenwood D; Eley A
    J Infect Dis; 1982 Jan; 145(1):110-7. PubMed ID: 6459389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro antibacterial activity of seven semi-synthetic penicillins against aerobic gram-negative bacteria and enterococci.
    Thabaut A; Durosoir JL; Saliou P
    Infection; 1982; 10 Suppl 3():S249-56. PubMed ID: 7152690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disk diffusion and serial dilution tests of susceptibility of some pathogenic gram-negative bacilli and enterococci to carbenicillin and ampicillin.
    Garner C; Rosner B; Finland M
    Antimicrob Agents Chemother; 1975 Aug; 8(2):172-86. PubMed ID: 810078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative in vitro activity of 5 semi-synthetic penicillins against aerobic Gram-negative bacilli and enterococci (author's transl)].
    Thabaut A; Durosoir JL; Saliou P
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):318-23. PubMed ID: 6460967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of mezlocillin and azlocillin compared with that of four other penicillins and two aminoglycosides.
    Barry AL; Thornsberry C; Jones RN; Gavan TL
    Cleve Clin Q; 1980; 47(4):311-9. PubMed ID: 6451334
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of clavulanic acid on the susceptibility of Bacteroides fragilis to three acyl-ureidopenicillins, ampicillin and carbenicillin.
    Simpson CN; Maskell JP; Williams JD
    J Antimicrob Chemother; 1984 Aug; 14(2):133-8. PubMed ID: 6334069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro examination of some new penicillin derivatives with activity against Pseudomonas aeruginosa: azlocillin, mezlocillin and piperacillin compared with carbenicillin].
    Høiby N; Bremmelgaard A; Schouenborg P
    Ugeskr Laeger; 1979 Oct; 141(41):2815-8. PubMed ID: 120049
    [No Abstract]   [Full Text] [Related]  

  • 18. Wide variability in Pseudomonas aeruginosa aminoglycoside results among seven susceptibility testing procedures.
    Staneck JL; Glenn S; DiPersio JR; Leist PA
    J Clin Microbiol; 1989 Oct; 27(10):2277-85. PubMed ID: 2511223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of inoculum size on the activity of carboxy- and ureido-penicillins and effects of combinations of ureido-penicillins with aminoglycosides against resistant Pseudomonas aeruginosa.
    Watanakunakorn C
    J Antimicrob Chemother; 1986 Jan; 17(1):91-5. PubMed ID: 3081474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agar (disk) diffusion test susceptibility of clinical isolates of Pseudomonas aeruginosa to azlocillin, cefotaxime, cefsulodin, lamoxactam, mezlocillin, and piperacillin.
    Traub WH
    Chemotherapy; 1982; 28(4):257-60. PubMed ID: 6288329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.